
Expert Contributor
Fernando Becerril Orta
Senior Partner
Becerril, Coca & Becerril
https://www.linkedin.com/in/fernando-becerril-72234521
https://twitter.com/BCB_IP
https://www.bcb.com.mx/
From marijuana to medication procurement, there are many pending issues that need to be clarified from a regulatory point of view.

Expert Contributor
Philippe Fournet-Fayard
CEO
Eolis
https://www.linkedin.com/in/philippe-fournet-fayard-8227685/?originalSubdomain=mx
http://eolis.com.mx/
Industries that invest for a long period of time in operations gain a huge benefit by focusing on total cost, including purchasing and operation.

Expert Contributor
Agustin Azcatl Romero
Patents Division Partner
Ortiz & Ramírez Abogados
https://www.linkedin.com/in/agustin-azcatl-4286862/
http://www.gelo.com.mx
IMPI provides a new dynamic for the pharma industry with the expectation that industrial property is used as a tool for growth and not as a barrier.